VanEck Australian Floating Rate ETF vs Eli Lilly And Co — how do they compare? VanEck Australian Floating Rate ETF trades at $50.98, while Eli Lilly And Co trades at $1,186.83 (market cap $1.03T). The key difference: Eli Lilly And Co pays a 0.6% dividend while VanEck Australian Floating Rate ETF pays none. Which is the better fit depends on your goals.
| FLOT | LLY | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $51.09 | $1.24K |
52-Week Low | $50.72 | $625.65 |
Market Cap | — | $1.03T |
Enterprise Value | — | $1.07T |
Dividend Yield | — | 0.6% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LLY trades at $1,154.27, down 2.6% today, amid a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q1 2026 EPS of $8.55 surpassing the $6.97 forecast. Revenue surged to $65.18B in 2025, driving a net income margin of 34.99%. Recent news includes the acquisition of AtaiBeckley for $2.8 billion, expanding its neuroscience pipeline.
Outlook remains positive with a consensus price target of $1,380, though high valuation multiples (P/E 41.09) and competitive pressures in obesity drugs present risks. Analyst sentiment is strongly bullish (73% buy ratings), supporting further upside if execution continues.
Trailing returns across standard periods
Latest headlines on both assets
FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →